Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial (Q72659567)
Jump to navigation
Jump to search
scientific article published on 01 October 1993
Language | Label | Description | Also known as |
---|---|---|---|
English | Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial |
scientific article published on 01 October 1993 |
Statements
Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial (English)
S J Duinkerke
P A Botter
A A Jansen
P A van Dongen
A J van Haaften
A J Boom
J H van Laarhoven
1 October 1993